b Tested in polyisoprene infusion pump reservoirs.
c Tested in PVC reservoirs for the Graseby 9000 ambulatory pumps.
d Tested in polyolefin-lined plastic bags.
e Tested with etoposide (BMS) 200 mg/L.
f Tested with etoposide (BMS) 125 mg/L
g Tested with etoposide (BMS) 175 mg/L.
h Tested with etoposide (BMS) 250 mg/L.
i Tested with etoposide (BMS) 350 mg/L.
j Tested with etoposide (BMS) 500 mg/L.
k Tested with etoposide phosphate (BMS) 600 mg/L.
l Tested with etoposide phosphate (BMS) 1.2 g/L.
m Tested with etoposide phosphate (BMS) 2 g/L.
n Tested with ondansetron HCl (GL) 480 mg/L.
o Tested with ondansetron HCl (GL) 960 mg/L.
p Tested with doxorubicin HCl (PHU) 40 mg/L.
q Tested with doxorubicin HCl (PHU) 25 mg/L.
r Tested with doxorubicin HCl (PHU) 35 mg/L.
s Tested with doxorubicin HCl (PHU) 50 mg/L.
t Tested with doxorubicin HCl (PHU) 70 mg/L.
u Tested with doxorubicin HCl (PHU) 100 mg/L.
v Tested with doxorubicin HCl (PHU) 120 mg/L.
w Tested with doxorubicin HCl (PHU) 240 mg/L.
x Tested with doxorubicin HCl (PHU) 400 mg/L.